Response to the letter-to-the-editor "In regard to: Dosimetric predictive factors for facial nerve paralysis after Cyberknife stereotactic radiotherapy for vestibular schwannomas: A single institution experience of 88 patients"
Radiother Oncol
.
2023 Oct:187:109797.
doi: 10.1016/j.radonc.2023.109797.
Epub 2023 Jul 7.
Authors
William Gehin
1
,
Benoîte Lassalle
2
,
Julia Salleron
3
,
René Anxionnat
4
,
Didier Peiffert
3
,
Vincent Marchesi
3
,
Valérie Bernier-Chastagner
3
Affiliations
1
Institut de Cancérologie de Lorraine, Radiotherapy, Nancy, France. Electronic address: w.gehin@nancy.unicancer.fr.
2
Centre Louis-Perquin Institut Régional de Réadaptation, Nancy, France.
3
Institut de Cancérologie de Lorraine, Radiotherapy, Nancy, France.
4
Centre Hospitalier Régional Universitaire de Nancy, Department of Neuroimaging, Nancy, France.
PMID:
37422268
DOI:
10.1016/j.radonc.2023.109797
No abstract available
Publication types
Letter
Comment
MeSH terms
Dose Fractionation, Radiation
Facial Nerve
Humans
Neuroma, Acoustic* / radiotherapy
Neuroma, Acoustic* / surgery
Paralysis
Treatment Outcome